Gyre Therapeutics
GYRE
#5615
Rank
A$1.51 B
Marketcap
$16.24
Share price
-0.58%
Change (1 day)
-40.02%
Change (1 year)

P/S ratio for Gyre Therapeutics (GYRE)

P/S ratio as of March 2025 (TTM): 9.11

According to Gyre Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.72. At the end of 2024 the company had a P/S ratio of 11.3.

P/S ratio history for Gyre Therapeutics from 2024 to 2024

Sep 2024Dec 2024101112companiesmarketcap.com

PS ratio at the end of each year

Year P/S ratio Change
202411.3